ID   RBP1_HUMAN              Reviewed;         655 AA.
AC   Q15311; D3DUI0;
DT   15-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 156.
DE   RecName: Full=RalA-binding protein 1;
DE            Short=RalBP1;
DE   AltName: Full=76 kDa Ral-interacting protein;
DE   AltName: Full=Dinitrophenyl S-glutathione ATPase;
DE            Short=DNP-SG ATPase;
DE   AltName: Full=Ral-interacting protein 1;
GN   Name=RALBP1; Synonyms=RLIP1, RLIP76;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INTERACTION WITH RALA.
RX   PubMed=7673236; DOI=10.1074/jbc.270.38.22473;
RA   Jullien-Flores V., Dorseuil O., Romero F., Letourneur F.,
RA   Saragosti S., Berger R., Tavitian A., Gacon G., Camonis J.H.;
RT   "Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with
RT   CDC42/Rac GTPase-activating protein activity.";
RL   J. Biol. Chem. 270:22473-22477(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND PROTEIN SEQUENCE OF
RP   2-15; 409-438 AND 472-486.
RC   TISSUE=Bone marrow;
RX   PubMed=10924126; DOI=10.1021/bi992964c;
RA   Awasthi S., Cheng J., Singhal S.S., Saini M.K., Pandya U., Pikula S.,
RA   Bandorowicz-Pikula J., Singh S.V., Zimniak P., Awasthi Y.C.;
RT   "Novel function of human RLIP76: ATP-dependent transport of
RT   glutathione conjugates and doxorubicin.";
RL   Biochemistry 39:9327-9334(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH REPS2.
RC   TISSUE=Brain;
RX   PubMed=9422736; DOI=10.1074/jbc.273.2.814;
RA   Ikeda M., Ishida O., Hinoi T., Kishida S., Kikuchi A.;
RT   "Identification and characterization of a novel protein interacting
RT   with Ral-binding protein 1, a putative effector protein of Ral.";
RL   J. Biol. Chem. 273:814-821(1998).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH CCNB1; CDK1; EPN1; NUMB AND TFAP2A.
RX   PubMed=12775724; DOI=10.1074/jbc.M302191200;
RA   Rosse C., L'Hoste S., Offner N., Picard A., Camonis J.;
RT   "RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to
RT   phosphorylate epsin during the switch off of endocytosis in mitosis.";
RL   J. Biol. Chem. 278:30597-30604(2003).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11437348; DOI=10.1006/abbi.2001.2395;
RA   Sharma R., Singhal S.S., Cheng J., Yang Y., Sharma A., Zimniak P.,
RA   Awasthi S., Awasthi Y.C.;
RT   "RLIP76 is the major ATP-dependent transporter of glutathione-
RT   conjugates and doxorubicin in human erythrocytes.";
RL   Arch. Biochem. Biophys. 391:171-179(2001).
RN   [8]
RP   INTERACTION WITH DAB2IP.
RX   PubMed=15310755; DOI=10.1074/jbc.M407617200;
RA   Zhang H., Zhang R., Luo Y., D'Alessio A., Pober J.S., Min W.;
RT   "AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-
RT   induced ASK1-JNK activation.";
RL   J. Biol. Chem. 279:44955-44965(2004).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92 AND SER-93, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92 AND SER-93, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-463, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29; SER-30; SER-34;
RP   SER-62; SER-92; SER-93; SER-461 AND SER-463, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-44; SER-48; SER-62;
RP   SER-92; SER-93; SER-463 AND SER-645, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   STRUCTURE BY NMR OF 393-446 IN COMPLEX WITH RALB, AND INTERACTION WITH
RP   RALB.
RX   PubMed=20696399; DOI=10.1016/j.str.2010.05.013;
RA   Fenwick R.B., Campbell L.J., Rajasekar K., Prasannan S.,
RA   Nietlispach D., Camonis J., Owen D., Mott H.R.;
RT   "The RalB-RLIP76 complex reveals a novel mode of ral-effector
RT   interaction.";
RL   Structure 18:985-995(2010).
CC   -!- FUNCTION: Can activate specifically hydrolysis of GTP bound to
CC       RAC1 and CDC42, but not RALA. Mediates ATP-dependent transport of
CC       S-(2,4-dinitrophenyl)-glutathione (DNP-SG) and doxorubicin (DOX)
CC       and is the major ATP-dependent transporter of glutathione
CC       conjugates of electrophiles (GS-E) and DOX in erythrocytes. Can
CC       catalyze transport of glutathione conjugates and xenobiotics, and
CC       may contribute to the multidrug resistance phenomenon. Serves as a
CC       scaffold protein that brings together proteins forming an
CC       endocytotic complex during interphase and also with CDK1 to switch
CC       off endocytosis, One of its substrates would be EPN1/Epsin.
CC       {ECO:0000269|PubMed:11437348, ECO:0000269|PubMed:12775724,
CC       ECO:0000269|PubMed:7673236}.
CC   -!- SUBUNIT: Interacts with the GTP-bound form of RALA, RALB, CDC42
CC       and RAC1. Interacts with REPS1 and REPS2 and this does not affect
CC       the Ral-binding activity. Interacts with DAB2IP. Interacts with
CC       catalytically active CCNB1 and CDK1 during mitosis. Interacts with
CC       EPN1, NUMB and TFAP2A during interphase and mitosis.
CC       {ECO:0000269|PubMed:12775724, ECO:0000269|PubMed:15310755,
CC       ECO:0000269|PubMed:20696399, ECO:0000269|PubMed:7673236,
CC       ECO:0000269|PubMed:9422736}.
CC   -!- INTERACTION:
CC       Q9H6F0:-; NbExp=3; IntAct=EBI-749285, EBI-10307481;
CC       Q9Y2J4-4:AMOTL2; NbExp=3; IntAct=EBI-749285, EBI-10187270;
CC       Q8TAB5:C1orf216; NbExp=5; IntAct=EBI-749285, EBI-747505;
CC       Q16204:CCDC6; NbExp=4; IntAct=EBI-749285, EBI-1045350;
CC       P78556:CCL20; NbExp=2; IntAct=EBI-749285, EBI-3913209;
CC       Q86XR8:CEP57; NbExp=4; IntAct=EBI-749285, EBI-308614;
CC       Q13227:GPS2; NbExp=7; IntAct=EBI-749285, EBI-713355;
CC       Q63ZY3:KANK2; NbExp=4; IntAct=EBI-749285, EBI-2556193;
CC       O60437:PPL; NbExp=3; IntAct=EBI-749285, EBI-368321;
CC       Q969G3:SMARCE1; NbExp=5; IntAct=EBI-749285, EBI-455078;
CC       Q86VP1:TAX1BP1; NbExp=3; IntAct=EBI-749285, EBI-529518;
CC       Q05BL0:TBRG1; NbExp=3; IntAct=EBI-749285, EBI-10223693;
CC       G5E9B5:TFPT; NbExp=5; IntAct=EBI-749285, EBI-10178002;
CC       Q15025:TNIP1; NbExp=3; IntAct=EBI-749285, EBI-357849;
CC       P43897:TSFM; NbExp=3; IntAct=EBI-749285, EBI-1049298;
CC       Q96C28:ZNF707; NbExp=5; IntAct=EBI-749285, EBI-748111;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:11437348};
CC       Peripheral membrane protein {ECO:0000269|PubMed:11437348}.
CC   -!- TISSUE SPECIFICITY: Expressed ubiquitously but at low levels.
CC       Shows a strong expression in the erythrocytes.
CC       {ECO:0000269|PubMed:11437348}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42542; AAB00103.1; -; mRNA.
DR   EMBL; CH471113; EAX01601.1; -; Genomic_DNA.
DR   EMBL; CH471113; EAX01602.1; -; Genomic_DNA.
DR   EMBL; CH471113; EAX01604.1; -; Genomic_DNA.
DR   EMBL; CH471113; EAX01605.1; -; Genomic_DNA.
DR   EMBL; BC013126; AAH13126.1; -; mRNA.
DR   CCDS; CCDS11845.1; -.
DR   PIR; F59435; F59435.
DR   RefSeq; NP_006779.1; NM_006788.3.
DR   UniGene; Hs.528993; -.
DR   PDB; 2KWH; NMR; -; A=393-446.
DR   PDB; 2KWI; NMR; -; B=393-446.
DR   PDB; 2MBG; NMR; -; A=184-446.
DR   PDBsum; 2KWH; -.
DR   PDBsum; 2KWI; -.
DR   PDBsum; 2MBG; -.
DR   ProteinModelPortal; Q15311; -.
DR   SMR; Q15311; -.
DR   BioGrid; 116131; 82.
DR   IntAct; Q15311; 49.
DR   MINT; MINT-140436; -.
DR   STRING; 9606.ENSP00000019317; -.
DR   DrugBank; DB00564; Carbamazepine.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB00398; Sorafenib.
DR   DrugBank; DB00541; Vincristine.
DR   TCDB; 9.A.1.1.1; the non abc multidrug exporter (n-mde) family.
DR   iPTMnet; Q15311; -.
DR   PhosphoSitePlus; Q15311; -.
DR   BioMuta; RALBP1; -.
DR   DMDM; 34098413; -.
DR   EPD; Q15311; -.
DR   MaxQB; Q15311; -.
DR   PaxDb; Q15311; -.
DR   PeptideAtlas; Q15311; -.
DR   PRIDE; Q15311; -.
DR   DNASU; 10928; -.
DR   Ensembl; ENST00000019317; ENSP00000019317; ENSG00000017797.
DR   Ensembl; ENST00000383432; ENSP00000372924; ENSG00000017797.
DR   GeneID; 10928; -.
DR   KEGG; hsa:10928; -.
DR   UCSC; uc002kob.4; human.
DR   CTD; 10928; -.
DR   DisGeNET; 10928; -.
DR   GeneCards; RALBP1; -.
DR   HGNC; HGNC:9841; RALBP1.
DR   HPA; CAB046010; -.
DR   HPA; HPA046651; -.
DR   MIM; 605801; gene.
DR   neXtProt; NX_Q15311; -.
DR   OpenTargets; ENSG00000017797; -.
DR   PharmGKB; PA34199; -.
DR   eggNOG; KOG4370; Eukaryota.
DR   eggNOG; ENOG410XRJ9; LUCA.
DR   GeneTree; ENSGT00840000129752; -.
DR   HOGENOM; HOG000007929; -.
DR   HOVERGEN; HBG044496; -.
DR   InParanoid; Q15311; -.
DR   KO; K08773; -.
DR   OMA; YDELMEW; -.
DR   OrthoDB; EOG091G01CT; -.
DR   PhylomeDB; Q15311; -.
DR   TreeFam; TF315411; -.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   SignaLink; Q15311; -.
DR   ChiTaRS; RALBP1; human.
DR   EvolutionaryTrace; Q15311; -.
DR   GeneWiki; RALBP1; -.
DR   GenomeRNAi; 10928; -.
DR   PRO; PR:Q15311; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000017797; -.
DR   CleanEx; HS_RALBP1; -.
DR   ExpressionAtlas; Q15311; baseline and differential.
DR   Genevisible; Q15311; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0016887; F:ATPase activity; IDA:UniProtKB.
DR   GO; GO:0043492; F:ATPase activity, coupled to movement of substances; TAS:UniProtKB.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:UniProtKB.
DR   GO; GO:0048365; F:Rac GTPase binding; IPI:UniProtKB.
DR   GO; GO:0017160; F:Ral GTPase binding; IPI:UniProtKB.
DR   GO; GO:0022857; F:transmembrane transporter activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006935; P:chemotaxis; TAS:ProtInc.
DR   GO; GO:0006897; P:endocytosis; IBA:GO_Central.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0043087; P:regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IPI:UniProtKB.
DR   GO; GO:0055085; P:transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006810; P:transport; IDA:UniProtKB.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   Pfam; PF00620; RhoGAP; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; GTPase activation; Membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|PubMed:10924126}.
FT   CHAIN         2    655       RalA-binding protein 1.
FT                                /FTId=PRO_0000056733.
FT   DOMAIN      192    380       Rho-GAP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00172}.
FT   REGION      403    499       Interaction with RalA.
FT   COMPBIAS    164    171       Poly-Lys.
FT   MOD_RES       2      2       N-acetylthreonine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      29     29       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      30     30       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      34     34       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      44     44       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      48     48       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      62     62       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      92     92       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      93     93       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     461    461       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     463    463       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     645    645       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VARIANT     617    617       A -> V (in dbSNP:rs35867116).
FT                                /FTId=VAR_049147.
FT   STRAND      184    187       {ECO:0000244|PDB:2MBG}.
FT   HELIX       194    200       {ECO:0000244|PDB:2MBG}.
FT   HELIX       211    222       {ECO:0000244|PDB:2MBG}.
FT   TURN        223    225       {ECO:0000244|PDB:2MBG}.
FT   TURN        228    232       {ECO:0000244|PDB:2MBG}.
FT   HELIX       237    248       {ECO:0000244|PDB:2MBG}.
FT   HELIX       255    257       {ECO:0000244|PDB:2MBG}.
FT   HELIX       260    273       {ECO:0000244|PDB:2MBG}.
FT   HELIX       280    291       {ECO:0000244|PDB:2MBG}.
FT   HELIX       296    309       {ECO:0000244|PDB:2MBG}.
FT   HELIX       312    334       {ECO:0000244|PDB:2MBG}.
FT   HELIX       339    350       {ECO:0000244|PDB:2MBG}.
FT   HELIX       354    367       {ECO:0000244|PDB:2MBG}.
FT   STRAND      384    386       {ECO:0000244|PDB:2MBG}.
FT   HELIX       395    414       {ECO:0000244|PDB:2KWH}.
FT   TURN        417    419       {ECO:0000244|PDB:2MBG}.
FT   HELIX       424    444       {ECO:0000244|PDB:2KWH}.
SQ   SEQUENCE   655 AA;  76063 MW;  EC6F75329FD8D062 CRC64;
     MTECFLPPTS SPSEHRRVEH GSGLTRTPSS EEISPTKFPG LYRTGEPSPP HDILHEPPDV
     VSDDEKDHGK KKGKFKKKEK RTEGYAAFQE DSSGDEAESP SKMKRSKGIH VFKKPSFSKK
     KEKDFKIKEK PKEEKHKEEK HKEEKHKEKK SKDLTAADVV KQWKEKKKKK KPIQEPEVPQ
     IDVPNLKPIF GIPLADAVER TMMYDGIRLP AVFRECIDYV EKYGMKCEGI YRVSGIKSKV
     DELKAAYDRE ESTNLEDYEP NTVASLLKQY LRDLPENLLT KELMPRFEEA CGRTTETEKV
     QEFQRLLKEL PECNYLLISW LIVHMDHVIA KELETKMNIQ NISIVLSPTV QISNRVLYVF
     FTHVQELFGN VVLKQVMKPL RWSNMATMPT LPETQAGIKE EIRRQEFLLN CLHRDLQGGI
     KDLSKEERLW EVQRILTALK RKLREAKRQE CETKIAQEIA SLSKEDVSKE EMNENEEVIN
     ILLAQENEIL TEQEELLAME QFLRRQIASE KEEIERLRAE IAEIQSRQQH GRSETEEYSS
     ESESESEDEE ELQIILEDLQ RQNEELEIKN NHLNQAIHEE REAIIELRVQ LRLLQMQRAK
     AEQQAQEDEE PEWRGGAVQP PRDGVLEPKA AKEQPKAGKE PAKPSPSRDR KETSI
//
